361 related articles for article (PubMed ID: 20807757)
1. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of the amyloid β-protein binding site on myelin basic protein.
Kotarba AE; Aucoin D; Hoos MD; Smith SO; Van Nostrand WE
Biochemistry; 2013 Apr; 52(15):2565-73. PubMed ID: 23510371
[TBL] [Abstract][Full Text] [Related]
3. Degradation of amyloid beta protein by purified myelin basic protein.
Liao MC; Ahmed M; Smith SO; Van Nostrand WE
J Biol Chem; 2009 Oct; 284(42):28917-25. PubMed ID: 19692707
[TBL] [Abstract][Full Text] [Related]
4. Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro.
Hoos MD; Ahmed M; Smith SO; Van Nostrand WE
Biochemistry; 2009 Jun; 48(22):4720-7. PubMed ID: 19385666
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein.
Hoos MD; Ahmed M; Smith SO; Van Nostrand WE
J Biol Chem; 2007 Mar; 282(13):9952-9961. PubMed ID: 17259179
[TBL] [Abstract][Full Text] [Related]
6. Localization of a fibrillar amyloid beta-protein binding domain on its precursor.
Van Nostrand WE; Melchor JP; Keane DM; Saporito-Irwin SM; Romanov G; Davis J; Xu F
J Biol Chem; 2002 Sep; 277(39):36392-8. PubMed ID: 12107175
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
8. N-terminal region of myelin basic protein reduces fibrillar amyloid-β deposition in Tg-5xFAD mice.
Ou-Yang MH; Xu F; Liao MC; Davis J; Robinson JK; Van Nostrand WE
Neurobiol Aging; 2015 Feb; 36(2):801-11. PubMed ID: 25457550
[TBL] [Abstract][Full Text] [Related]
9. The role of histidines in amyloid β fibril assembly.
Brännström K; Islam T; Sandblad L; Olofsson A
FEBS Lett; 2017 Apr; 591(8):1167-1175. PubMed ID: 28267202
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
11. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
12. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
Ou-Yang MH; Van Nostrand WE
J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for self-propagation of different amyloid-β fibril conformations.
Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
17. New Mechanism of Amyloid Fibril Formation.
Galzitskaya O
Curr Protein Pept Sci; 2019; 20(6):630-640. PubMed ID: 30686252
[TBL] [Abstract][Full Text] [Related]
18. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
19. The Absence of Myelin Basic Protein Reduces Non-Amyloidogenic Processing of Amyloid Precursor Protein.
Seiwa C; Sugiyama I; Sugawa M; Murase H; Kudoh C; Asou H
Curr Alzheimer Res; 2021; 18(4):326-334. PubMed ID: 34218780
[TBL] [Abstract][Full Text] [Related]
20. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides.
Naito A; Kawamura I
Biochim Biophys Acta; 2007 Aug; 1768(8):1900-12. PubMed ID: 17524351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
